HomeNewsBusinessMarketsHome and away: Indian pharma firms reap the best of both worlds in Q1 FY24

Home and away: Indian pharma firms reap the best of both worlds in Q1 FY24

Vaibhavi Ranjan • August 30, 2023 / 11:45 IST

Improved pricing and competitive environment in the US and resilient sales in the domestic market aided an uptick in revenue. Easing raw material inflation and lower freight soothed margin pressure.

Pharma companies posted more hits than misses in the Q1 earnings season.

To read the full story,

Are you a PRO subscriber? Sign In

Ad free Experience

Seamless navigation, faster responses.
Expert Perspective

Explore 230+ exclusive editorials every month
+

Uncover Insights from World-Renowned Experts and Journalists
Actionable Insights

40+ weekly investment ideas + 3 to 4 daily technical calls
Virtual Events

Exclusive Live Webinars for Expert Trading & Investment Strategies!
Newsletters

Stay ahead with daily and weekly insights

Unlock exclusive discounts